Statistics for Amplitude Surgical SAS (id:10840 AMPLI)
Valuation metrics
Market cap
150.63M
Enterprise value
240.65M
Trailing P/E (ttm)
104.67
Forward P/E
PEG ratio
Price/Sales (ttm)
1.42
Price/Book (mrq)
1.59
Enterprise Value/Revenue
2.27
Enterprise Value/EBITDA
10.54
Overview
Shares outstanding
47.97M
Float
Shares short
% Held by insiders
0.01%
% Held by institutions
0.75%
Average volume (10 days)
86.00
Average volume (90 days)
Price summary
52-Week low
2.70
52-Week high
3.58
52-Week change
8.05%
Beta
0.49
50-Day moving average
3.16
200-Day moving average
3.16
Dividends and splits
Forward annual dividend rate
Forward annual dividend yield
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
June 30th, 2024
Most recent quarter (mrq)
June 30th, 2024
Profitability
Profit margin
1.41%
Operating margin
38.61%
Operational effectiveness
Return on assets
0.55%
Return on equity
1.59%
Income statement
Revenue (ttm)
Revenue per share (ttm)
Quarterly revenue growth (yoy)
-0.96
Gross profit (ttm)
83.68M
EBITDA
22.83M
Net income to common (ttm)
1.50M
Diluted EPS (ttm)
0.03
Quarterly earnings growth (yoy)
-96.10%
Balance sheet
Total cash (mrq)
27.12M
Total cash per share (mrq)
Total debt (mrq)
119.12M
Total Debt/Equity (mrq)
1.24
Current ratio (mrq)
201.78%
Book value per share (mrq)
1.97
Cash flow
Cash flow statement
-5,276,000.00
Levered free cash flow (LFCF)
1.53M